tient's visual acuity was 20/200, and although the majority of the cornea was nonedematous, there was marked corneal edema in the area of the GV markings with bulla noted (Figure 1) . Over several weeks, the edema gradually resolved with interface haze in the area of prior edema. The visual acuity resolved to 20/40 without correction.
Case 2. A 67-year-old woman with a history of Fuchs endothelial dystrophy presented with gradual onset of blurry vision of the right eye. On examination, it was found that her best-corrected visual acuity was 20/60 in the right eye and 20/30 in the left eye. There was 3ϩ guttata with 1ϩ edema of the right eye. There was a well-centered posterior chamber intraocular lens on the right. His left eye had 1ϩ guttata and a 1ϩ nuclear sclerotic cataract. An uneventful DSAEK was performed (thickness of graft unknown).
On postoperative day 1, the graft was fully attached, there was 2ϩ diffuse corneal edema present, and her visual acuity was 3/200. The edema was most prominent in the area of the purple markings (Figure 2) . At postoperative week 1, the patient's visual acuity was unchanged. Interface haze was noted at the area of the markings. At the 2-week postoperative visit, her visual acuity was 20/ 400, and her best-corrected visual acuity was 20/80. No change occurred 1 month after surgery. At postoperative week 6, the patient had a best-corrected visual acuity of 20/40 with a clear cornea.
Comment. Using a rabbit model, Chang et al 5 illustrated that endothelial cells are destroyed via the effects of the dye. We presume that the eventual improvement of the edema over time with gradual visual rehabilitation results from the compensatory measures of the surrounding unaffected cells. Current best practice dictates that a surgeon preserve as many endothelial cells as possible during DSAEK. Given the novelty of DSAEK, we do not know the natural history of a DSAEK graft in terms of longevity. However, if one applies the same logic as that used for a penetrating keratoplasty, the reasonable conclusion is to presume that more endothelial cells will result in a better chance for long-term graft survival. The findings behind this case report are limited given the sample size. However, given the data in the previously reported studies, [1] [2] [3] [4] [5] in conjunction with our clinical observations, we recommend that the use of GV (including the dose and duration of exposure) on donor grafts be limited as much as possible because of concern over irreversible damage to the corneal endothelium. grams divided by height in meters squared] of Ͻ17.5), (2) an intense fear of gaining weight, (3) a disturbance in the evaluation of one's own body shape, and (4) amenorrhea. 1 Anorexia nervosa has the highest mortality of any psychiatric illness and has a lifetime estimated prevalence of 0.9% in women and 0.3% in men, with a standardized mortality ratio of 45 for patients whose lifetime nadir BMI is less than 10.5.
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We describe 5 patients with severe anorexia nervosa who were admitted to the ACUTE Center and who complained of dry, irritated eyes and photophobia. Examination revealed lagophthalmos in the setting of enophthalmos and pseudoptosis with a narrowed palpebral fissure, with multiple other starvationmediated medical complications. Protective measures, including the use of sterile topical ophthalmic ointment and taping shut the eyelids every night, with the use of topical lubrication during the day, in addition to volume repletion and modest weight restoration, resolved both the lagophthalmos and the secondary ocular exposure symptoms. We will describe 1 case in detail and make mention of the other 4 cases.
Report of Cases. Case 1.
A 26-yearold woman with anorexia nervosa was admitted to our institution with a height of 1.524 m (5 ft), a weight of 25.5 kg (56.7 lb), a BMI of 10.9, and a percentage of ideal body weight of 56%. In her first week of hospitalization, her medical complications included volume depletion, bradycardia, hypoglycemia in the single digits, hyponatremia, pancytopenia, starvation hepatitis, dysphagia causing aspiration, patulous eustachian tubes with autophonia, and refeeding hypophosphatemia. On the day of admission, she also complained of dry, irritated eyes with photophobia, and an initial examination showed pseudoptosis and enophthalmos, which were not formally measured, and 1-mm lagophthalmos. Topical lubrication was prescribed, with several drops of artificial tears in each eye hourly during the day and a ribbon of sterile ophthalmic ointment followed by direct taping of the eyelids during the night. The patient's weight reached its nadir on hospital day 5, at 23.8 kg (52.8 lb), and on hospital day 11, without any improvement in her symptoms, she was evaluated by an ophthalmologist. Examination confirmed enophthalmos bilaterally and 1-mm lagophthalmos, and corneal inspection revealed mild bilateral punctate epithelial erosions without frank defects or ulceration. Continued topical protection with nightly taping was recommended, and on hospital day 24, the patient's symptoms had resolved completely, with a weight increase from nadir of 4.5 kg (10 lb; Tables 1 and 2) .
Remaining Cases. In the remaining 4 cases, each young woman with multiorgan dysfunction related to severe anorexia nervosa noted eye discomfort shortly after admission, and examination by the attending internist confirmed pseudoptosis, enophthalmos, and lagophthalmos. Patients' symptomatic responses to topical protective measures were rapid and were associated with resolution of the lagophthalmos, and thus no ophthalmology consultation was requested in these cases.
Case 2. A 27-year-old woman with anorexia nervosa was admitted to our institution with a height of 1.727 m (5 ft, 8 in) and a weight of 29.9 kg (65.8 lb), giving her a BMI of 10 and a percentage of ideal body weight of 47%. On hospital day 6, her eye symptoms developed and persisted for 10 days after topical treatment was initiated, until the patient had gained 1 kg from her nadir weight.
Case 3. A 24-year-old woman with anorexia nervosa was admitted to our institution with a height of 1.676 m (5 ft, 6 in) and a weight of 26.9 kg (59.2 lb), giving her a BMI of 9.5 and a percentage of ideal body weight of 46%. On the day of admission, she noted eye symptoms that resolved after 11 days of topical treatment. At the time of resolution, her weight had increased from its nadir by 1.3 kg.
Case 4. A 34-year-old woman with anorexia nervosa was admitted to our institution with a height of 1.524 m (5 ft), a weight of 23.8 kg (52 lb), a BMI of 10.2, and a percentage of ideal body weight of 52%. On the day of admission, she noted eye symptoms that resolved 4 days after topical treatments were instituted, at which point her weight had increased by 3.1 kg, much of which was related to improvement in volume status.
Case 5. A 21-year-old woman with anorexia nervosa was admitted to our institution with a height of 1.651 m (5 ft, 5 in), a weight of 31.2 kg (68.6 lb), a BMI of 11.4, and a percentage of ideal body weight of 55%. On hospital day 2, she described dry, irritated eyes. By hospital day 12, with a weight increase of 3.8 kg and attention to protective topical treatments, her symptoms had resolved. 
